Study Stopped
Study did not get funded
The Effect of Water Intake on Glucose Regulation
INDIGO-I
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
There is a growing body of evidence suggesting low water intake and elevated levels of the hormone vasopressin exacerbate glucose regulation. This project will examine the physiological mechanism by which low water intake impairs glucose homeostasis. In the current proposal we aim to: 1) quantify the degree of glucose impairment as a response to elevated vasopressin due to low water intake and 2) identify the physiological mechanism by which elevated vasopressin, as a response to low water intake, impairs glucose regulation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2018
CompletedFirst Posted
Study publicly available on registry
December 5, 2018
CompletedStudy Start
First participant enrolled
February 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2019
CompletedAugust 28, 2019
August 1, 2019
2 months
December 3, 2018
August 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
amount of glucose metabolized M
amount of glucose metabolized during the euglycemic \& Hyperglycemic clamp
220-240 min & 340-360 min of the protocol
metabolic clearance rate for insulin
metabolic clearance rate for insulin during the euglycemic \& Hyperglycemic clamp
220-240 min & 340-360 min of the protocol
quantity of glucose metabolized per unit plasma insulin concentration
quantity of glucose metabolized per unit plasma insulin concentration during the euglycemic \& Hyperglycemic clamp
220-240 min & 340-360 min of the protocol
Rate of glucose appearance & disappearance
Rate of glucose appearance \& disappearance during the euglycemic \& Hyperglycemic clamp
220-240 min & 340-360 min of the protocol
Secondary Outcomes (3)
Plasma copeptin
0 min, 240 min & 360 min of the protocol
glucagon
0 min, 240 min & 360 min of the protocol
Cortisol
0 min, 240 min & 360 min of the protocol
Study Arms (2)
High Water intake
ACTIVE COMPARATOR5-days of High water intake according to IOM guidelines
Low Water Intake
EXPERIMENTAL5-days of Low water intake of 500 mL/day
Interventions
for 5 days prior to each experiment subjects will undergo manipulation of their water intake.
Eligibility Criteria
You may qualify if:
- BMI 27.5-35
You may not qualify if:
- BMI \<27.5 or \>35
- high physical activity
- diabetes
- impaired liver or kidney function
- cardiovascular disease
- weight change of more than 3 kg in the past month
- pregnancy
- previous surgery on digestive tract (except appendectomy)
- serotonin re-uptake inhibitors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Nutrition
Study Record Dates
First Submitted
December 3, 2018
First Posted
December 5, 2018
Study Start
February 11, 2019
Primary Completion
April 3, 2019
Study Completion
April 29, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share